Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Ochoa

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Oncoimmunology|June 5, 2013
High-density lipoproteins delivering interleukin-15Maria C Ochoa, Ignacio Melero, Pedro Berraondo
Cancer Discovery|August 3, 2019
Immune Desertic Landscapes in Hepatocellular Carcinoma Shaped by β-Catenin ActivationPedro Berraondo, Maria C Ochoa, Irene Olivera, et al.
Methods in Enzymology|January 18, 2020
Rapid isolation and enrichment of mouse NK cells for experimental purposesMaite Alvarez, Maria C Ochoa, Luna Minute, et al.
Current Gene Therapy|November 20, 2012
Interleukin-15 in gene therapy of cancerMaria C Ochoa, Guillermo Mazzolini, Sandra Hervas-Stubbs, et al.
International Review of Cell and Molecular Biology|July 7, 2022
Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatmentCordelia Dunai, Erik Ames, Maria C Ochoa, et al.
Current Opinion in Immunology|February 26, 2017
Targeting NK-cell checkpoints for cancer immunotherapyAura Muntasell, Maria C Ochoa, Luna Cordeiro, et al.
Cureus|May 13, 2025
Adhesive Strips vs. Sutures in Lumbar Spinal Fusion: A Non-inferiority Analysis of Surgical Site InfectionsFernando A Núñez-Moreno, Christian Bepperling, Carlos Trenado, et al.
Cancer Research|November 15, 2012
Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion proteinMaria C Ochoa, Jessica Fioravanti, Inmaculada Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2020
IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and ImmunotherapyAlvaro Teijeira, Saray Garasa, Maria C Ochoa, et al.
EMBO Molecular Medicine|October 2, 2023
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodiesIgnacio Melero, Maria C Ochoa, Carmen Molina, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Oncoimmunology|June 5, 2013
High-density lipoproteins delivering interleukin-15Maria C Ochoa, Ignacio Melero, Pedro Berraondo
Cancer Discovery|August 3, 2019
Immune Desertic Landscapes in Hepatocellular Carcinoma Shaped by β-Catenin ActivationPedro Berraondo, Maria C Ochoa, Irene Olivera, et al.
Methods in Enzymology|January 18, 2020
Rapid isolation and enrichment of mouse NK cells for experimental purposesMaite Alvarez, Maria C Ochoa, Luna Minute, et al.
Current Gene Therapy|November 20, 2012
Interleukin-15 in gene therapy of cancerMaria C Ochoa, Guillermo Mazzolini, Sandra Hervas-Stubbs, et al.
International Review of Cell and Molecular Biology|July 7, 2022
Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatmentCordelia Dunai, Erik Ames, Maria C Ochoa, et al.
Current Opinion in Immunology|February 26, 2017
Targeting NK-cell checkpoints for cancer immunotherapyAura Muntasell, Maria C Ochoa, Luna Cordeiro, et al.
Cureus|May 13, 2025
Adhesive Strips vs. Sutures in Lumbar Spinal Fusion: A Non-inferiority Analysis of Surgical Site InfectionsFernando A Núñez-Moreno, Christian Bepperling, Carlos Trenado, et al.
Cancer Research|November 15, 2012
Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion proteinMaria C Ochoa, Jessica Fioravanti, Inmaculada Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2020
IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and ImmunotherapyAlvaro Teijeira, Saray Garasa, Maria C Ochoa, et al.
EMBO Molecular Medicine|October 2, 2023
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodiesIgnacio Melero, Maria C Ochoa, Carmen Molina, et al.
Pageof 3